Insulin-like growth factor (IGF)-1 is a critical endogenous neuroprotectant and low normal levels of peptide hormone are associated with increased morbidity and mortality in ischemic heart disease and stroke [13]–[15]. This evidence concerns the gene IGF1 and stroke disorder.